Research

Hormonal

Inhibition of miR-122 using antisense therapy significantly reduces circulating cholesterol and triglyceride levels in the liver.

Anti-miR-122 therapy is a potential future treatment for fatty liver and high cholesterol. It works by blocking a specific liver RNA (miR-122) that normally promotes cholesterol production. Current management relies on diet and exercise, but this pathway may soon be targetable by drugs.

ModerateSupportsMEDIUM confidence
Anti-miR-122 therapy resulted in a significant reduction (25%–30%) of circulating cholesterol levels.
Zhihong Yang et al. · Acta Pharmaceutica Sinica B · 2015

Why this rating

Review paper citing multiple in vivo studies.

Source

Emerging role of microRNAs in lipid metabolism

Zhihong Yang et al. · Acta Pharmaceutica Sinica B · 2015

DOI 10.1016/j.apsb.2015.01.002

narrative_reviewCited 173×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →